Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET
STO:IBT.B Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
883.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.00K | -73.00K | -94.81% |
| Dec 31, 2023 | 77.00K | 65.00K | 541.67% |
| Dec 31, 2022 | 12.00K | -82.00K | -87.23% |
| Dec 31, 2021 | 94.00K | -218.00K | -69.87% |
| Dec 31, 2020 | 312.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | 238.00K | 76.00K | 46.91% |
| Dec 31, 2016 | 162.00K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 0 | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| BioInvent International AB | 217.86M |
| Genovis AB (publ.) | 131.09M |
| Oncopeptides AB | 83.24M |
| Corline Biomedical AB | 10.67M |
| Medivir AB | 9.01M |
| Xspray Pharma AB | 2.47M |
| FluoGuide | 349.42K |
Infant Bacterial Therapeutics AB News
- 2 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Infant Bacterial Therapeutics AB Annual report: Q4 2025 - Filings
- 6 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q4 2025 - Filings
- 9 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Infant Bacterial Therapeutics AB Quarterly report: Q2 2025 - Filings